Access cutting-edge lung cancer treatment through this clinical trial at a research site in Redlands. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Redlands at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The purpose of ARTEMIDE-Lung03 is to evaluate the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with platinum-based doublet chemotherapy, as a first-line treatment of patients with non-squamous mNSCLC whose tumors express PD-L1.
Sponsor: AstraZeneca
Check if you qualify for this lung cancer clinical trial in Redlands, CA
If you're searching for lung cancer treatment options in Redlands, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Redlands research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.